Cite
Koirala J, Gyanwali P, Gerzoff RB, et al. Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study. Open Forum Infect Dis. 2021;8(8):ofab391doi: 10.1093/ofid/ofab391.
Koirala, J., Gyanwali, P., Gerzoff, R. B., Bhattarai, S., Nepal, B., Manandhar, R., Jha, R., Sharma, S., Sharma, Y. R., Bastola, A., Murphy, H., Acharya, S., Adhikari, P., Rajkarnikari, M., Vaidya, K. M., Panthi, C. L., Bista, B., Giri, G., Aryal, S., Pant, S., Pokharel, A., Karki, S., Basnet, S., Koirala, B., Dhimal, M. (2021). Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study. Open forum infectious diseases, 8(8), ofab391. https://doi.org/10.1093/ofid/ofab391
Koirala, Janak, et al. "Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study." Open forum infectious diseases vol. 8,8 (2021): ofab391. doi: https://doi.org/10.1093/ofid/ofab391
Koirala J, Gyanwali P, Gerzoff RB, Bhattarai S, Nepal B, Manandhar R, Jha R, Sharma S, Sharma YR, Bastola A, Murphy H, Acharya S, Adhikari P, Rajkarnikari M, Vaidya KM, Panthi CL, Bista B, Giri G, Aryal S, Pant S, Pokharel A, Karki S, Basnet S, Koirala B, Dhimal M. Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study. Open Forum Infect Dis. 2021 Aug 21;8(8):ofab391. doi: 10.1093/ofid/ofab391. eCollection 2021 Aug. PMID: 34430672; PMCID: PMC8379705.
Copy
Download .nbib
